Literature DB >> 17061084

Superselective arterial infusion chemotherapy for squamous cell carcinomas of the oral cavity: histopathologic effects on metastatic neck lymph nodes.

I Ikushima1, Y Korogi, A Ishii, T Hirai, M Yamura, R Nishimura, Y Baba, Y Yamashita, M Shinohara.   

Abstract

We have performed superselective intra-arterial infusion chemotherapy (SIC) on carcinomas of the oral cavity according to a protocol in which the distribution of the drug was evaluated by the use of a combined CT and angiography system, and the chemotherapy was combined with medium-dose conformal radiation therapy (CRT). The purpose of this study was to evaluate the pathological effect of this treatment on the metastatic neck lymph nodes (LNs). Twenty consecutive patients who had metastatic neck LNs from squamous cell carcinomas of the mouth and who underwent both SIC and CRT were included in this study, in which a total of 22 LNs were evaluated. A microcatheter was placed in the appropriate feeding artery of the tumor, such as the internal maxillary artery, facial artery, lingual artery and external carotid artery (ECA), and cisplatin (50 mg/body) was infused twice through a microcatheter. The CRT was administered with a dual-energy (4 and 10 MV) linear accelerator. The total and daily doses delivered were 30 and 2.0 Gy, respectively. Intra-arterial infusion to the LNs was divided into two groups: superselective infusion (mainly to the submandibular LNs via the facial artery, n = 10) and nonsuperselective infusion via the ECA (n = 12). The distribution of cisplatin into the LNs was confirmed by slow-infusion CT. Histopathologic effects on the LNs were evaluated on the specimens obtained during the operation and classified into five grades (0: no or minimal response: I: disappearance of less than three quarters of the tumor cells: II: disappearance of more than three quarters of the tumor cells: III: disappearance of viable tumor cells with a small amount of residual nonviable tumor cells: IV: complete disappearance of all viable and nonviable tumor cells). Grade 0 or 1 was defined as poor response and Grade II or more as good response. Twenty-three LNs from nine patients without CRT and SIC were served as control. In the superselective infusion group, all 10 LNs showed good response (response rate, 100%: grade II = 4, grade III = 3, grade IV = 3). In the non-superselective group, however, 6 of 12 LNs showed poor response (response rate, 50%: grade 0 = 2, grade I = 4, grade II = 2, grade III = 2, grade IV = 2). All 23 control LNs with no treatment showed grade 0 response. Superselective infusion seems necessary to obtain good histopathologic effects on the metastatic LNs. SIC combined with CRT can be applied to the metastatic LNs.

Entities:  

Mesh:

Year:  2006        PMID: 17061084     DOI: 10.1007/s00405-006-0183-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

1.  Superselective continuous arterial infusion chemotherapy through the superficial temporal artery for oral cavity tumors.

Authors:  T Nakasato; K Katoh; M Sone; S Ehara; Y Tamakawa; H Hoshi; S Sekiyama
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

2.  Superselective intraarterial chemotherapy in combination with irradiation: preliminary report.

Authors:  T Shimizu; Y Sakakura; T Hattori; N Yamaguchi; M Kubo; K Sakakura
Journal:  Am J Otolaryngol       Date:  1990 Mar-Apr       Impact factor: 1.808

3.  A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers.

Authors:  D K Cheung; J Regan; M Savin; V Gibberman; W Woessner
Journal:  Cancer       Date:  1988-03-01       Impact factor: 6.860

4.  Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors.

Authors:  Y Y Lee; I W Dimery; P Van Tassel; C De Pena; J B Blacklock; H Goepfert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-04

5.  Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers.

Authors:  S Imai; Y Kajihara; O Munemori; T Kamei; T Mori; T Handa; K Akisada; Y Orita
Journal:  Eur J Radiol       Date:  1995-12-15       Impact factor: 3.528

6.  An organ-preserving selective arterial chemotherapy strategy for head and neck cancer.

Authors:  C W Kerber; W H Wong; S B Howell; K Hanchett; K T Robbins
Journal:  AJNR Am J Neuroradiol       Date:  1998-05       Impact factor: 3.825

7.  Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth: preliminary clinical experience.

Authors:  Y Korogi; T Hirai; R Nishimura; S Hamatake; Y Sakamoto; R Murakami; Y Baba; A Arakawa; M Takahashi; Y Uji
Journal:  AJR Am J Roentgenol       Date:  1995-11       Impact factor: 3.959

Review 8.  Intraarterial chemotherapy for head and neck cancer, Part 2: Clinical experience.

Authors:  S R Baker; R Wheeler
Journal:  Head Neck Surg       Date:  1984 Jan-Feb

9.  Intra-arterial chemotherapy for head and neck cancer. An update on the totally implantable infusion pump.

Authors:  S R Baker; A A Forastiere; R Wheeler; B R Medvec
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-11

10.  Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.

Authors:  Adorján F Kovács; Mirko Schiemann; Bernd Turowski
Journal:  J Craniomaxillofac Surg       Date:  2002-04       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.